Avoro Capital Advisors LLC - Dec 31, 2024 SCHEDULE 13G/A Report for Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: GLUE
Shares outstanding: 61.2M shares
Disclosed Ownership: 4.35M shares
Ownership: 7.1%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 09:30 AM
Date of event: Dec 31, 2024
Next filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	7.1%	4.35M	4.35M	0	/s/ Scott Epstein	Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh	7.1%	4.35M	4.35M	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually